CN104257719B - 消肿散结的中西药多用途软膏及其制备方法 - Google Patents
消肿散结的中西药多用途软膏及其制备方法 Download PDFInfo
- Publication number
- CN104257719B CN104257719B CN201410541747.8A CN201410541747A CN104257719B CN 104257719 B CN104257719 B CN 104257719B CN 201410541747 A CN201410541747 A CN 201410541747A CN 104257719 B CN104257719 B CN 104257719B
- Authority
- CN
- China
- Prior art keywords
- grams
- ointment
- raw material
- chinese
- western medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 54
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 230000008961 swelling Effects 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 229940037003 alum Drugs 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 16
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 16
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 16
- 239000004863 Frankincense Substances 0.000 claims abstract description 16
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 16
- 241000208682 Liquidambar Species 0.000 claims abstract description 16
- 235000006552 Liquidambar styraciflua Nutrition 0.000 claims abstract description 16
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 16
- 235000011477 liquorice Nutrition 0.000 claims abstract description 16
- 239000010446 mirabilite Substances 0.000 claims abstract description 16
- 239000011347 resin Substances 0.000 claims abstract description 16
- 229920005989 resin Polymers 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 15
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 15
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 15
- 229940116229 borneol Drugs 0.000 claims abstract description 15
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 15
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 235000014347 soups Nutrition 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 5
- 235000008216 herbs Nutrition 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 4
- 238000005303 weighing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 238000007920 subcutaneous administration Methods 0.000 description 9
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000006071 cream Substances 0.000 description 5
- 206010020718 hyperplasia Diseases 0.000 description 5
- 210000005075 mammary gland Anatomy 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000003176 fibrotic effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 206010051458 Myometritis Diseases 0.000 description 3
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 240000009023 Myrrhis odorata Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 241000272814 Anser sp. Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 206010012426 Dermal cyst Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010305 Epidermal Cyst Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010034016 Paronychia Diseases 0.000 description 1
- 241000029132 Paronychia Species 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- -1 alum Chemical compound 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了消肿散结的中西药多用途软膏,所述软膏由如下重量配比的原料制备而成:白矾20‑30克,制乳香10‑15克,制没药10‑15克,冰片10‑20克,白胶香10‑15克,玄明粉20‑30克,鱼石脂软膏50‑100克。本发明还公开了上述软膏的制备方法,按如下步骤进行:(1)按原料重量配比将白矾、制乳香、制没药、冰片及白胶香五味药材混合,碾碎成100目的粉末,然后按原料重量配比加入玄明粉、鱼石脂软膏,混合搅拌均匀,得到混合物;(2)将混合物高温灭菌,然后装袋或装瓶备用。本发明相比现有技术具有以下优点:用途广、疗效高、且无毒副作用,治愈率能达到100%,且原料价格低,药源广泛,制作工艺简单。
Description
技术领域
本发明涉及一种软膏及其制备方法,尤其涉及的是一种消肿散结的中西药多用途软膏及其制备方法。
背景技术
软膏在人们日常生活中应用广泛,但现有的软膏大多用途单一,不能同时针对多种病症进行治疗,尤其是对于一些疑难杂症,某些甚至为内服外吊药物难于奏效的疾病,诸如乳腺小叶增生、皮下纤维瘤、附件包块、子宫肌炎、输卵管卵巢炎等,现有的软膏不能起到治疗作用。
发明内容
本发明的目的在于克服现有技术的不足,提供了一种消肿散结的中西药多用途软膏及其制备方法。
本发明是通过以下技术方案实现的:
消肿散结的中西药多用途软膏,所述软膏由如下重量配比的原料制备而成:
白矾20-30克,制乳香10-15克,制没药10-15克,冰片10-20克,白胶香10-15克,玄明粉20-30克,鱼石脂软膏50-100克。
作为上述的消肿散结的中西药多用途软膏的一种优选配方,所述软膏由如下重量配比的原料制备而成:
白矾25克,制乳香12克,制没药12克,冰片15克,白胶香12克,玄明粉25克,鱼石脂软膏75克。
本发明还提供了上述的消肿散结的中西药多用途软膏的制备方法,该制备方法按如下步骤进行:
(1)按原料重量配比将白矾、制乳香、制没药、冰片及白胶香五味药材混合,碾碎成100目的粉末,然后按原料重量配比加入玄明粉、鱼石脂软膏,混合搅拌均匀,得到混合物;
(2)将混合物高温灭菌,然后装袋或装瓶备用。
本发明提供的消肿散结的中西药多用途软膏的份量仅为治疗一个痈肿的剂量,若用于乳腺小叶增生或盆腔炎等,其所需之剂量约为本申请组合物份量的3-6倍。
本发明提供的消肿散结的中西药多用途软膏的使用方法为:
外用时将软膏涂布于纱布块上,乳房用园型纱布块,少腹用正方型纱布块,附件用长方型纱布块,涂膏之厚度约5毫米左右,外敷后以胶布固定,每日早晚各换药一次;
本软膏对皮下脂肪瘤(粉瘤)无效,不必外用。盆腔炎及痈疽患者在外用软膏期间,严禁食用公鸡、鲤鱼、牛肉、鹅肉及辣椒等辛热发物。
本发明提供的消肿散结的中西药多用途软膏,主要是通过清热解毒,软坚散结,化痰祛瘀,活血消肿的原理来达到治疗目的的。其中各味原料药物性能如下:
白矾:酸、涩,寒。解毒消肿,化痰燥湿,收涩止泻,杀虫止痒。
制乳香:苦、辛,温。行气,活血,消肿,止痛。
制没药:苦,平。功能与主治均跟制乳香相同。
冰片:苦、辛,微寒。开窍醒神,清热止痛,明目退翳。
白胶香:苦、涩,平。解毒、止痛、活血、凉血、生肌。
玄明粉:咸、苦,寒。软坚散结,清热泻火,泻下通便。
鱼石脂软膏:成品,作粘合剂用。抑菌防腐,消炎散肿,敛湿止痒。
本软膏的制备原料中除了鱼石脂软膏外,其余的六味药物皆有多种功能,六味药物中每味药不仅均可内服,而且也都是外用之要药。本膏剂之所以疗效高用途广,正是因为这六味药物有其特殊的性能。将软膏用于皮下局部由热毒所致的疽疖痈肿,盖因白矾可解毒化瘀消肿,玄明粉可清热软坚散结,白胶香可解毒凉血止痛,凡未化脓者外敷后很快可以得到消散。将软膏用于皮下局部非细菌性的包块也非常有效,像乳腺小叶增生和皮下纤维瘤这两种疾患,首先从病理学角度来看,皆由气血瘀滞和痰浊凝阻而形成的,再从中医理论学来看,痰浊既可以内生于脏腑之中,也可流窜于经络和肌肉之间,因此这两种疾病除有气滞血瘀外,也有痰浊阻遏之存在;这正是软膏中制乳香、制没药、白矾、玄明粉、白胶香等,可活血消肿、软坚散结、化痰祛瘀的功效之所及。此外,软膏中的几种药物其酸、辛、咸等味各具,拥有较强的皮下渗透力,尤其是冰片芳香通窍开腠理透肌肤,在膏剂中作为使药,可载诸药直透入皮下肌肉深层组织之中。鉴此,申请人由表及里,进一步将软膏应用于盆腔感染,对于子宫肌炎和附件炎患者来说,在内服中药汤剂之同时外用本膏,可使疗程大为缩短加速痊愈。软膏中的玄明粉、白矾、冰片、白胶香等,不仅对于盆腔炎症有较强的清热解毒止痛之功能,并且外用于为气滞血瘀或痰浊阻结的卵巢囊肿和输卵管包块,软膏中的制乳香、制没药、白矾、玄明粉等,也有较好的消肿化瘀散结燥湿之功能。
本发明相比现有技术具有以下优点:
本发明提供的消肿散结的中西药多用途软膏,其所用之药物品种较少,但药力强疗效高,不仅对于诸如乳腺小叶增生、皮下纤维瘤、附件包块、子宫肌炎、输卵管卵巢炎等疑难杂症能获取完美的疗效;同时针对痈肿、疖疽、乳腺炎、甲沟炎等,凡未化脓者皆可使之消散;此外还可用于外敷跌打损伤能起到很好的疗效;其用途广、疗效高、且无毒副作用,治愈率能达到100%,且其所组成的原料价格极低,药源非常广泛,制作工艺简单,适于临床推广应用。
具体实施方式
下面对本发明的实施例作详细说明,本实施例在以本发明技术方案为前提下进行实施,给出了详细的实施方式和具体的操作过程,但本发明的保护范围不限于下述的实施例。
实施例一
本实施例提供的消肿散结的中西药多用途软膏,由如下重量配比的原料制备而成:
白矾20克,制乳香10克,制没药10克,冰片10克,白胶香10克,玄明粉20克,鱼石脂软膏50克。
本实施例还提供了上述的消肿散结的中西药多用途软膏的制备方法,该制备方法按如下步骤进行:
(1)按原料重量配比将白矾、制乳香、制没药、冰片及白胶香五味药材混合,碾碎成100目的粉末,然后按原料重量配比加入玄明粉、鱼石脂软膏,混合搅拌均匀,得到混合物;
(2)将混合物高温灭菌,然后装袋或装瓶备用。
实施例二
本实施例提供的消肿散结的中西药多用途软膏,由如下重量配比的原料制备而成:
白矾25克,制乳香12克,制没药12克,冰片15克,白胶香12克,玄明粉25克,鱼石脂软膏75克。
其制备方法同实施例一。
实施例三
本实施例提供的消肿散结的中西药多用途软膏,由如下重量配比的原料制备而成:
白矾30克,制乳香15克,制没药15克,冰片20克,白胶香15克,玄明粉30克,鱼石脂软膏100克。
其制备方法同实施例一。
采用上述三个实施例制备的消肿散结的中西药多用途软膏,多年来运用于临床,治愈痈肿患者20多例,疗程5天左右。治愈约小于鸡卵的皮下纤维瘤发生于胸部和额部的各1例,疗程约10天左右。治愈乳腺小叶增生者,其乳房为瘦小型的8例,疗程约10天左右;其乳房为丰满型的9例,外用本膏结合内服中药汤剂,疗程约10天左右。治愈输卵管包块5例,卵巢囊肿3例,疗程约两星期左右。总之凡属急性或亚急性盆腔炎之患者,外用本膏其少腹疼痛或带下增多等症状,均可有效地得到控制。治疗效果显著,治愈率达到了100%。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (3)
1.消肿散结的中西药多用途软膏,其特征在于,所述软膏由如下重量配比的原料制备而成:
白矾20-30克,制乳香10-15克,制没药10-15克,冰片10-20克,白胶香10-15克,玄明粉20-30克,鱼石脂软膏50-100克。
2.如权利要求1所述的消肿散结的中西药多用途软膏,其特征在于,所述软膏由如下重量配比的原料制备而成:
白矾25克,制乳香12克,制没药12克,冰片15克,白胶香12克,玄明粉25克,鱼石脂软膏75克。
3.如权利要求1或2所述的消肿散结的中西药多用途软膏的制备方法,其特征在于,该制备方法按如下步骤进行:
(1)按原料重量配比将白矾、制乳香、制没药、冰片及白胶香五味药材混合,碾碎成100目的粉末,然后按原料重量配比加入玄明粉、鱼石脂软膏,混合搅拌均匀,得到混合物;
(2)将混合物高温灭菌,然后装袋或装瓶备用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410541747.8A CN104257719B (zh) | 2014-09-30 | 2014-09-30 | 消肿散结的中西药多用途软膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410541747.8A CN104257719B (zh) | 2014-09-30 | 2014-09-30 | 消肿散结的中西药多用途软膏及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104257719A CN104257719A (zh) | 2015-01-07 |
CN104257719B true CN104257719B (zh) | 2017-12-12 |
Family
ID=52149376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410541747.8A Expired - Fee Related CN104257719B (zh) | 2014-09-30 | 2014-09-30 | 消肿散结的中西药多用途软膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104257719B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105663157A (zh) * | 2016-01-23 | 2016-06-15 | 赵志富 | 一种治疗火烧烫伤的药物及其制备方法 |
CN107412632A (zh) * | 2017-03-24 | 2017-12-01 | 梁玉湘 | 一种治疗甲沟炎的药膏及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526392A (zh) * | 2011-12-20 | 2012-07-04 | 何明华 | 一种消肿止痛的药物及其制备方法 |
CN103071093A (zh) * | 2013-01-17 | 2013-05-01 | 遵义县南白镇华南药房 | 一种治疗妇科疾病的药物 |
-
2014
- 2014-09-30 CN CN201410541747.8A patent/CN104257719B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526392A (zh) * | 2011-12-20 | 2012-07-04 | 何明华 | 一种消肿止痛的药物及其制备方法 |
CN103071093A (zh) * | 2013-01-17 | 2013-05-01 | 遵义县南白镇华南药房 | 一种治疗妇科疾病的药物 |
Non-Patent Citations (1)
Title |
---|
《拨云眼膏》;于维萍;《新编中成药手册》;20020930;第720页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104257719A (zh) | 2015-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104644943A (zh) | 中药组合物、含该组合物的药灸及制备方法 | |
CN103169830B (zh) | 一种治疗闭合性软组织损伤的外用药酒 | |
CN110013496A (zh) | 一种治疗颈肩腰腿痛的中药配方 | |
CN104257719B (zh) | 消肿散结的中西药多用途软膏及其制备方法 | |
CN103845578B (zh) | 治疗烧烫伤、褥疮、带状疱疹外用酊剂及制备方法 | |
CN105194351A (zh) | 一种治疗骨病的中药膏 | |
CN102552612A (zh) | 一种接骨中药 | |
CN103223076B (zh) | 一种治疗骨折内服中药 | |
CN104027742A (zh) | 一种口服治疗纤维肌痛综合征中药组合物 | |
CN104083568A (zh) | 一种苗医骨痛膏药及其制备方法 | |
CN104997890B (zh) | 一种治疗骨折的中药制剂 | |
CN100361679C (zh) | 一种香樟根活络镇痛药 | |
CN103230535A (zh) | 一种具有活络镇痛作用的药酒 | |
CN112603986A (zh) | 一种多功效的艾姜热灸膏及其制备方法 | |
CN105770796A (zh) | 一种治疗软组织损伤药酒搽剂 | |
CN105560639A (zh) | 一种治疗带状孢疹多形渗出性红斑的中药 | |
CN104547032A (zh) | 用于瘀血痹阻证的中成药 | |
CN105311520A (zh) | 一种治疗跌打损伤中药搽剂 | |
CN110478418A (zh) | 一种镇痛生肌的擦剂 | |
CN108524697A (zh) | 一种治疗前列腺炎和增生的药物 | |
CN109432060A (zh) | 一种用于治疗风寒咳嗽的灸贴及其制备方法 | |
CN108653588A (zh) | 一种治疗骨科疾病的外敷中药 | |
CN101244138B (zh) | 一种治疗冻伤的外用中药制剂 | |
CN104225082A (zh) | 一种烫烧伤膏 | |
CN105920193A (zh) | 一种治疗风湿寒疼引起筋缩血瘀病的药酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171212 |